Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments
November 08, 2024 08:00 ET
|
Monopar Therapeutics Inc.
In-licensed ALXN-1840 (a Late-Stage Wilson Disease Drug Candidate) from Alexion, AstraZeneca Rare DiseaseTwo Novel Radiopharma Clinical Trials now Active and Enrolling Patients with Advanced Solid...
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
November 07, 2024 08:00 ET
|
HilleVax, Inc.
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...
Aveanna Healthcare Holdings Announces Third Quarter 2024 Financial Results and Revised 2024 Outlook
November 07, 2024 06:30 ET
|
Aveanna Healthcare Holdings, Inc
Third Quarter Revenue was $509.0 million, a 6.5% increase over the prior year period Gross margin increased 8.4% to $159.7 million, compared to Q3 2023 Third Quarter Net loss was $42.8 million,...
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024
November 05, 2024 16:05 ET
|
InnovAge
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
FISCAL FIRST QUARTER ENDED SEPTEMBER 30, 2024
Pacific Health Care Organization, Inc. Reports its Third Quarter 2024 Results
November 05, 2024 12:26 ET
|
Pacific Health Care Organization, Inc.
Irvine, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) last Friday filed with the Securities and Exchange Commission (the “Commission”) its...
Patria Reports Third Quarter 2024 Earnings Results
November 05, 2024 06:00 ET
|
Patria Investments Limited
GRAND CAYMAN, Cayman Islands, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Patria (Nasdaq:PAX) reported today its unaudited results for the third quarter ended September 30, 2024. The full detailed...
First National Corporation Reports Third Quarter 2024 Financial Results
November 01, 2024 16:00 ET
|
First National Corporation
First National Corporation Reports Third Quarter 2024 Financial Results
Dorman Products, Inc. Reports Third Quarter 2024 Results; Raises Full Year 2024 Earnings Guidance
October 31, 2024 16:01 ET
|
Dorman Products, Inc.
Highlights (All comparisons are to the prior year period unless otherwise noted): Net sales of $503.8 million, up 3.2% compared to $488.2 millionDiluted earnings per share (“EPS”) of $1.80, up 41%...
VEON to release 3Q 2024 trading update on 14 November 2024
October 31, 2024 08:00 ET
|
VEON Ltd.
VEON to release 3Q 2024 trading update on 14 November 2024 Amsterdam and Dubai, 31 October 2024 – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator, today confirms...
Paylocity Announces First Quarter Fiscal Year 2025 Financial Results
October 30, 2024 16:05 ET
|
Paylocity Corporation
Q1 2025 Recurring & Other Revenue of $333.1 million, up 14% year-over-yearQ1 2025 Total Revenue of $363.0 million, up 14% year-over-yearAcquisition of Airbase, a modern finance and spend...